STD 119 Parameters

STD 119 Parameters is a comprehensive sexually transmitted infection testing package designed to help individuals in Dubai monitor and protect their sexual health. The package screens for a broad spectrum of common bacterial and viral STIs and evaluates relevant aspects of reproductive and genital tract health to detect signs of infection or inflammation that may need further attention. Testing is performed using standard laboratory methods and results are provided to support informed follow-up with your healthcare provider. Prioritizing regular screening with this package helps maintain personal well‑being and supports public health in the UAE community.

• Chlamydia Trachomatis
• Gardnerella Vaginalis
• Mycoplasma Genitalium
• Mycoplasma Hominis
• Neisseria Gonorrhoeae
• Treponema Pallidum
• Ureaplasma Parvum
• Ureaplasma Urealyticum
• Haemophilus Ducreyi
• Herpes Simplex Virus Type 1
• Herpes Simplex Virus Type 2
• Trichomonas Vaginalis
• Atopobium Vaginae
• Bacteroides Fragilis
• BVAB2
• Candida Albicans
• Candida Dubliniensis
• Candida Glabrata
• Candida Krusei
• Candida Lusitaniae
• Candida Parapsilosis
• Candida Tropicalis
• Cytomegalovirus (CMV)
• Lactobacillus sp.
• Lymphogranuloma Venereum (LGV)
• Megasphaera Type 1
• Mobiluncus spp.
• Varicella Zoster Virus (VZV)
• Chlamydia Antigen
• Culture and Sensitivity (Urine)
• Hepatitis B Surface Antigen (HBsAg)
• Hepatitis C Antibodies (Anti-HCV)
• Herpes Simplex Virus Type 1 IgG Antibody
• Herpes Simplex Virus Type 1 IgM Antibody
• Herpes Simplex Virus Type 2 IgG Antibody
• Herpes Simplex Virus Type 2 IgM Antibody
• HIV I & II Antibody and P24 Antigen
• Rapid Plasma Reagin (RPR)
• Treponema Pallidum Hemagglutination (TPHA)
• HBV DNA Detection by Real-Time PCR (Qualitative)
• HCV RNA Detection by Real-Time PCR (Qualitative)
• HIV-1 RNA Detection by Real-Time PCR (Qualitative)
• HIV-2 RNA Detection by Real-Time PCR (Qualitative)
• HPV 40 Genotyping (40 Types)
• UTI 16 Profile by PCR (16 Pathogens)
• Urine Analysis Routine (20 Parameters)

• Sexually active adults, especially those with new or multiple partners, who may want routine STI screening.
• People who recently had unprotected sex or condom failure and are seeking timely comprehensive testing for reassurance.
• Anyone notified by a partner or healthcare professional about possible exposure and considering full STI assessment.
• Individuals with a past history of an STI who may benefit from follow‑up testing or periodic monitoring.
• Residents and expatriates in Dubai looking for confidential, comprehensive sexual‑health screening as part of routine care.

Preparing for the STD 119 Parameters package helps ensure a smooth and accurate testing experience. This discreet sexual health panel is offered through Touch Connect in Dubai; providing clear information about symptoms and recent exposures will assist clinicians in delivering appropriate care. If you have questions, check your booking details for any facility-specific instructions.

• Bring a valid Emirates ID or passport and your Touch Connect booking confirmation.
• Be prepared to describe any recent symptoms, sexual contacts, or potential exposures.
• Provide your medical history and note any known allergies to the clinician.
• Arrive on time and follow any instructions sent by the testing facility after booking.

Your STD 119 Parameters report provides clear results for the infection markers and sexual health parameters included in this package, helping you see which areas were tested and how your values compare with reference ranges. Results should always be interpreted in the context of symptoms, medical history, age, gender and other relevant clinical factors rather than taken alone.

• Review any abnormal or borderline findings carefully — an abnormal result does not automatically mean a disease is present and often requires clinical correlation.
• Share the report with your primary care physician or a sexual health specialist in Dubai to discuss what the results mean for your health and lifestyle.
• Consider repeat testing when clinically appropriate, especially for borderline results or if symptoms persist.
• Follow your clinician’s advice about further testing or specialist consultation when recommended to clarify results and agree next steps.